Neurocrine Biosciences (NBIX) Amortizatization of Intangibles (2010 - 2026)

Neurocrine Biosciences' Amortizatization of Intangibles history runs 17 years deep, the most recent figure standing at $1.3 million for Q1 2026.

• Quarterly Amortizatization of Intangibles fell 71.74% year-over-year to $1.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.4 million (down 60.34% YoY) and the FY2025 annual result came in at $12.7 million, down 51.53% from the prior year.
• Amortizatization of Intangibles was $1.3 million for Q1 2026 at Neurocrine Biosciences, down from $2.0 million in the prior quarter.
• Across five years, Amortizatization of Intangibles topped out at $7.1 million in Q1 2024 and bottomed at -$3.7 million in Q4 2022.
• A 5-year average of $3.9 million and a median of $4.2 million in 2023 frame the typical range for Amortizatization of Intangibles.
• Annual changes were most pronounced in 2023 — Amortizatization of Intangibles jumped 270.27% — and 2026, when it sank 71.74%.
• Neurocrine Biosciences' Amortizatization of Intangibles stood at -$3.7 million in 2022, then soared by 270.27% to $6.3 million in 2023, then slipped by 11.11% to $5.6 million in 2024, then tumbled by 64.29% to $2.0 million in 2025, then slumped by 35.0% to $1.3 million in 2026.
• Business Quant data shows NBIX's Amortizatization of Intangibles at $1.3 million in Q1 2026, $2.0 million in Q4 2025, and $2.7 million in Q3 2025.